Detection of implantable lead failures by differential EGM analysis
First Claim
1. An automated method of diagnosing an anomaly in an implantable lead of an implantable cardioverter defibrillator (ICD) attached to a single-coil defibrillation lead that includes conductors connected to a first low-voltage electrode and a second low-voltage electrode and a high-voltage coil electrode, comprising:
- monitoring electrogram (EGM) signals from a Reference EGM defined by a pathway between the first and the second low-voltage electrodes through the conductors in the implantable lead and a Diagnostic EGM defined by a pathway between the high-voltage coil electrode and the first low-voltage electrode through conductors in the implantable lead;
automatically determining valid ventricular events in the Reference EGM;
automatically comparing the Diagnostic EGM with the Reference EGM to determine if noncardiac signals other than valid ventricular events are present on the Diagnostic EGM; and
in response to the presence of noncardiac signals other than valid ventricular events on the Diagnostic EGM, automatically initiating one or more responses selected from the group consisting of;
initiating one or more additional diagnostic tests to confirm that the electrode responsible for the noncardiac signals shorts the defibrillation pathway,initiating a patient alert, andinitiating a remote-monitoring alert.
1 Assignment
0 Petitions
Accused Products
Abstract
A method and system for the diagnosis of anomalies in a lead attached to an implantable medical device, such as an implantable cardioverter defibrillator (ICD), including an insulation breach resulting in a short circuit of the high-voltage shock pulse. Determination that the defibrillation pathway is shorted may be made by initial analysis of a Reference EGM and Diagnostic EGM and subsequent analysis of Differential Diagnostic EGMs. Upon determining if a specific defibrillation pathway is shorted, the nonessential defibrillation electrode of that pathway may be excluded from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Alternatively, the ICD system can confirm the presence of a lead anomaly with one or more alternative diagnostic approaches. Patient and remote-monitoring alerts may be initiated.
-
Citations
6 Claims
-
1. An automated method of diagnosing an anomaly in an implantable lead of an implantable cardioverter defibrillator (ICD) attached to a single-coil defibrillation lead that includes conductors connected to a first low-voltage electrode and a second low-voltage electrode and a high-voltage coil electrode, comprising:
-
monitoring electrogram (EGM) signals from a Reference EGM defined by a pathway between the first and the second low-voltage electrodes through the conductors in the implantable lead and a Diagnostic EGM defined by a pathway between the high-voltage coil electrode and the first low-voltage electrode through conductors in the implantable lead; automatically determining valid ventricular events in the Reference EGM; automatically comparing the Diagnostic EGM with the Reference EGM to determine if noncardiac signals other than valid ventricular events are present on the Diagnostic EGM; and in response to the presence of noncardiac signals other than valid ventricular events on the Diagnostic EGM, automatically initiating one or more responses selected from the group consisting of; initiating one or more additional diagnostic tests to confirm that the electrode responsible for the noncardiac signals shorts the defibrillation pathway, initiating a patient alert, and initiating a remote-monitoring alert. - View Dependent Claims (2, 3, 4, 5, 6)
-
Specification